Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Clinical Diagnostics Market: By Test, By Product, By End User and Geography
Clinical Diagnostics Market size was valued at US$ 50.11 billion in 2023, growing at a significant CAGR of 5.02% over 2024-2030. Some of the key factors influencing the market growth include growth in patients with long-term diseases/ disorders like diabetes, cardiovascular diseases, hypertension, etc. where frequent testing is required. Also increase in the geriatric population plays a key role in the market. Expansion and advancements of these diagnostic tests are also thriving the market growth. An increase in health expenditure, rising in awareness about health care, and testing in people are the important factors of the market growth.
However, the high requirement of initial capital amount, stringent regulations by the government, complex operating procedure of equipment, and lack of skilled professionals are somehow restraining the market in some regions. Clinical diagnostics is the process of identifying a disease by signs, symptoms, a patient's medical history, and a physical examination. They include the production, development, and marketing of test kits, automated test systems, and informatics systems. They aid in disease management to enhance patients' overall health and well-being. They also assist in the classification of patients with various diseases so that focused medication can be given to them. Additionally, they can enhance the effectiveness of medicines, forecast therapeutic efficacy, and protect patients from long-term problems. As a result, clinical diagnostics are widely used in point-of-care testing, diagnostic laboratories, and hospital laboratories all over the world.
Study Period
2024-2030Base Year
2023CAGR
5.02%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The development of complex and specialised tests for early illness diagnosis and disease management, as well as rising demand for lab automation, are expected to fuel expansion in the worldwide clinical diagnostics market throughout the forecast period. The growing use of point-of-care diagnostics has ushered in a trend of decentralisation in the healthcare business.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 50.11 billion |
Market CAGR |
5.02% |
By Test Type |
|
By Product |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global clinical diagnostics market size was valued at US$ 50.11 billion in 2023, growing at a CAGR of 5.02% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The key players of the market are Abbott Laboratories, ARUP Laboratories, Bioscientia Healthcare, Bio-Rad Laboratories Inc. Bio-Reference Laboratories, BioMerieux, Charles River, Laboratories, Clarient Inc., Danaher Corporation, Becton Dickinson and Company, Diasorin, Genoptix Medical Laboratory, Genzyme Corporation, Healthscope Limited., Hologic Inc, Labco S.A., Laboratory Corporation of America, Holdings (LabCorp), Ortho Clinical Diagnostics, Qiagen, Quest Diagnostics Inc., Roche Diagnostics, Siemens AG Healthcare Sonic Healthcare Ltd, Thermo Fisher Scientific.
1.Executive Summary |
2.Global Clinical Diagnostics Market Introduction |
2.1.Global Clinical Diagnostics Market - Taxonomy |
2.2.Global Clinical Diagnostics Market - Definitions |
2.2.1.Test Type |
2.2.2.Product |
2.2.3.End User |
2.2.4.Region |
3.Global Clinical Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Clinical Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Clinical Diagnostics Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Lipid Panel |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Metabolic Panel |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Liver Panel |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Renal Panel |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Complete Blood Count |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Electrolyte Testing |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Infectious Disease Testing |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Other Tests |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
6.Global Clinical Diagnostics Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Instruments |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Reagents |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Data Management Systems |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Clinical Diagnostics Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Laboratory |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Point-of-Care Testing |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Other End Users |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Clinical Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Lipid Panel |
9.1.2.Metabolic Panel |
9.1.3.Liver Panel |
9.1.4.Renal Panel |
9.1.5.Complete Blood Count |
9.1.6.Electrolyte Testing |
9.1.7.Infectious Disease Testing |
9.1.8.Other Tests |
9.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Instruments |
9.2.2.Reagents |
9.2.3.Data Management Systems |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital |
9.3.2.Diagnostic Laboratory |
9.3.3.Point-of-Care Testing |
9.3.4.Other End Users |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Lipid Panel |
10.1.2.Metabolic Panel |
10.1.3.Liver Panel |
10.1.4.Renal Panel |
10.1.5.Complete Blood Count |
10.1.6.Electrolyte Testing |
10.1.7.Infectious Disease Testing |
10.1.8.Other Tests |
10.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Instruments |
10.2.2.Reagents |
10.2.3.Data Management Systems |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital |
10.3.2.Diagnostic Laboratory |
10.3.3.Point-of-Care Testing |
10.3.4.Other End Users |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Lipid Panel |
11.1.2.Metabolic Panel |
11.1.3.Liver Panel |
11.1.4.Renal Panel |
11.1.5.Complete Blood Count |
11.1.6.Electrolyte Testing |
11.1.7.Infectious Disease Testing |
11.1.8.Other Tests |
11.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Instruments |
11.2.2.Reagents |
11.2.3.Data Management Systems |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital |
11.3.2.Diagnostic Laboratory |
11.3.3.Point-of-Care Testing |
11.3.4.Other End Users |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Lipid Panel |
12.1.2.Metabolic Panel |
12.1.3.Liver Panel |
12.1.4.Renal Panel |
12.1.5.Complete Blood Count |
12.1.6.Electrolyte Testing |
12.1.7.Infectious Disease Testing |
12.1.8.Other Tests |
12.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Instruments |
12.2.2.Reagents |
12.2.3.Data Management Systems |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital |
12.3.2.Diagnostic Laboratory |
12.3.3.Point-of-Care Testing |
12.3.4.Other End Users |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Lipid Panel |
13.1.2.Metabolic Panel |
13.1.3.Liver Panel |
13.1.4.Renal Panel |
13.1.5.Complete Blood Count |
13.1.6.Electrolyte Testing |
13.1.7.Infectious Disease Testing |
13.1.8.Other Tests |
13.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Instruments |
13.2.2.Reagents |
13.2.3.Data Management Systems |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital |
13.3.2.Diagnostic Laboratory |
13.3.3.Point-of-Care Testing |
13.3.4.Other End Users |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories |
14.2.2.ARUP Laboratories |
14.2.3.Bioscientia Healthcare |
14.2.4.Bio-Rad Laboratories Inc. |
14.2.5.Bio-Reference Laboratories |
14.2.6.BioMerieux |
14.2.7.Charles River Laboratories |
14.2.8.Clarient Inc. |
14.2.9.Danaher Corporation |
14.2.10.Becton, Dickinson and Company |
14.2.11.Diasorin |
14.2.12.Genoptix Medical Laboratory |
14.2.13.Genzyme Corporation |
14.2.14.Healthscope Limited. |
14.2.15.Hologic Inc |
14.2.16.Labco S.A. |
14.2.17.Laboratory Corporation of America Holdings (LabCorp) |
14.2.18.Ortho Clinical Diagnostics |
14.2.19.Qiagen |
14.2.20.Quest Diagnostics Inc. |
14.2.21.Roche Diagnostics |
14.2.22.Siemens AG Healthcare |
14.2.23.Sonic Healthcare Ltd |
14.2.24.Thermo Fisher Scientific |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players